What We're Reading: Page 219
Industry reads hand-picked by our editors
Oct 15, 2019
Oct 14, 2019
Oct 11, 2019
Oct 10, 2019
Oct 09, 2019
-
STAT
The return of Vioxx: Can a drug once deemed deadly be relaunched to treat rare disease?
-
Reuters
Cracks in Purdue's proposed opioid settlement as Arizona backs out
-
Regulatory Focus
EMA Staff Losses Tick Up as Workload Increases
-
Bloomberg Government
AbbVie, Bristol-Myers Among Patient Advocacy Groups' Big Backers
Oct 08, 2019
Oct 07, 2019
-
The New York Times
Nobel Prize in Medicine Awarded to 3 for Work on Cells
-
ProPublica
Pharmaceutical Companies Are Luring Mexicans Across the U.S. Border to Donate Blood Plasma
-
The Wall Street Journal
Biotech Has a Supply Problem